FDAnews
www.fdanews.com/articles/131087-pneumrx-gets-ce-mark-for-lung-volume-reduction-coil-system

PneumRx Gets CE Mark for Lung Volume Reduction Coil System

October 14, 2010
PneumRX has received CE Marking for its RePneu Lung Volume Reduction Coil System to treat late stage emphysema. The device is designed to implant coils into the lungs to compress damaged tissue and restore elasticity in healthier lung tissue. The system is a minimally invasive alternative to surgery, according to the company. PneumRX intends to launch the product in Europe later this year.